Public Profile

Camber Pharmaceuticals Inc.

Camber Pharmaceuticals Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a key provider of high-quality generic and specialty medications, focusing on areas such as cardiovascular health, pain management, and infectious diseases. With a commitment to innovation and quality, Camber Pharmaceuticals offers a diverse portfolio of products that stand out for their efficacy and affordability. The company has achieved significant milestones, including numerous FDA approvals, which have solidified its position in the competitive generics market. Recognised for its dedication to patient care and safety, Camber Pharmaceuticals continues to expand its operational reach, serving healthcare providers and patients across various regions in the US.

DitchCarbon Score

How does Camber Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Camber Pharmaceuticals Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Camber Pharmaceuticals Inc.'s reported carbon emissions

Camber Pharmaceuticals Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or defined initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, it is essential for companies like Camber Pharmaceuticals to establish clear climate commitments and reduction strategies to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Camber Pharmaceuticals Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Camber Pharmaceuticals Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Camber Pharmaceuticals Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Glenmark Pharmaceuticals

IN
Pharmaceutical Preparation Manufacturing
Updated 16 minutes ago

Dr Reddys Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Cipla

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Unichem Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Alkem Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated 26 minutes ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers